...
首页> 外文期刊>Journal of critical care >Exposure keratopathy: Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults
【24h】

Exposure keratopathy: Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults

机译:曝光角病:令人遗憾的成年人在危重成年人暴露角病的发病率,危险因素和影响

获取原文
获取原文并翻译 | 示例

摘要

PurposeWe aimed to determine the rate of exposure keratopathy (EK) in critically ill patients, identify risk factors for developing EK and ascertain the effectiveness of a protocol to prevent EK. Materials and methodsWe undertook a two-phase prospective cohort study in a general adult ICU with first-phase being observational and an eye care protocol was introduced in the second-phase. Daily ophthalmic assessment was carried out along with recording of various risk factors. ResultsWe studied 371 patients. In the first phase, the overall rate of EK was 21% but the rate in mechanically ventilated patients was 56%; χ2(1,N=257)=80.8,p<0.001. Adjusted odds ratios (AOR) for development of EK was 28.6 (8.19–43.37), 13.0 (3.16–54.38) and 1.2 (1.03–1.33) with incomplete eye closure, mechanical ventilation, and higher sequential organ failure assessment score respectively. Following the introduction of the protocol, the overall rate of EK reduced to 2.6% (3 cases); χ2(1,N=371)=18.6,p<0.001. ConclusionsEK is common in critically ill patients and a simple protocol substantially reduces the incidence of EK and is easily achieved in clinical practice.
机译:目的旨在确定危重患者的暴露角病(EK)的曝光率,确定开发EK的危险因素,并确定议定书的有效性以防止ek。材料和方法在一般成年ICU中进行了两阶段预期队列研究,其中具有一阶段是观察性的,在第二阶段引入了眼部护理方案。每日眼科评估以及录制各种风险因素。结果我们研究了371名患者。在第一阶段,ek的总体速率为21%,但机械通风患者的速率为56%; χ2(1,n = 257)= 80.8,p <0.001。 EK开发的调整差距(AOR)是28.6(8.19-43.37),13.0(3.16-54.38)和1.2(1.03-1.33),分别不完全闭合,机械通气和更高的顺序器官失效评估分数。在介绍方案后,ek的总体率降至2.6%(3例); χ2(1,n = 371)= 18.6,p <0.001。结论Sek在危重病患者中常见,简单的方案显着降低了EK的发生率,并且在临床实践中很容易实现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号